These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12504925)

  • 1. Acetyl-l-carnitine induces muscarinic antinocieption in mice and rats.
    Ghelardini C; Galeotti N; Calvani M; Mosconi L; Nicolai R; Bartolini A
    Neuropharmacology; 2002 Dec; 43(7):1180-7. PubMed ID: 12504925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prochlorperazine induces central antinociception mediated by the muscarinic system.
    Ghelardini C; Galeotti N; Uslenghi C; Grazioli I; Bartolini A
    Pharmacol Res; 2004 Sep; 50(3):351-8. PubMed ID: 15225680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception.
    Galeotti N; Bartolini A; Calvani M; Nicolai R; Ghelardini C
    Neuropharmacology; 2004 Aug; 47(2):286-94. PubMed ID: 15223307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antinociceptive effects of centrally administered CDP-choline on acute pain models in rats: the involvement of cholinergic system.
    Hamurtekin E; Gurun MS
    Brain Res; 2006 Oct; 1117(1):92-100. PubMed ID: 16942753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of muscarinic receptor subtypes in central antinociception.
    Bartolini A; Ghelardini C; Fantetti L; Malcangio M; Malmberg-Aiello P; Giotti A
    Br J Pharmacol; 1992 Jan; 105(1):77-82. PubMed ID: 1375858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8.
    Ghelardini C; Galeotti N; Casamenti F; Malmberg-Aiello P; Pepeu G; Gualtieri F; Bartolini A
    Life Sci; 1996; 58(25):2297-309. PubMed ID: 8649219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of acetyl-L-carnitine on neuropathic pain and apoptosis: a role for the nicotinic receptor.
    Di Cesare Mannelli L; Ghelardini C; Calvani M; Nicolai R; Mosconi L; Toscano A; Pacini A; Bartolini A
    J Neurosci Res; 2009 Jan; 87(1):200-7. PubMed ID: 18709658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of histamine in rodent antinociception.
    Malmberg-Aiello P; Lamberti C; Ghelardini C; Giotti A; Bartolini A
    Br J Pharmacol; 1994 Apr; 111(4):1269-79. PubMed ID: 8032614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
    Hamurtekin E; Bagdas D; Gurun MS
    Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of muscarinic antinociception by antisense inhibition of M(1) receptors.
    Ghelardini C; Galeotti N; Bartolini A
    Br J Pharmacol; 2000 Apr; 129(8):1633-40. PubMed ID: 10780968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of cholinergic and opioid receptor mechanisms in fluoxetine mediated antinociception response in streptozotocin-induced diabetic mice.
    Anjaneyulu M; Chopra K
    Eur J Pharmacol; 2006 May; 538(1-3):80-4. PubMed ID: 16650402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociception induced by SM 32 depends on a central cholinergic mechanism.
    Ghelardini C; Galeotti N; Gualtieri F; Novella Romanelli M; Bartolini A
    Pharmacol Res; 1997 Feb; 35(2):141-7. PubMed ID: 9175584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice.
    Galeotti N; Quattrone A; Vivoli E; Bartolini A; Ghelardini C
    Neuroscience; 2007 Oct; 149(2):409-20. PubMed ID: 17890015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive profile of 3-alpha-tropanyl 2-(4-Cl-phenoxy)butyrate (SM-21) [corrected]: a novel analgesic with a presynaptic cholinergic mechanism of action.
    Ghelardini C; Galeotti N; Gualtieri F; Bellucci C; Manetti D; Giotti A; Malmberg-Aiello P; Galli A; Bartolini A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):430-9. PubMed ID: 9223584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive and antiamnesic properties of the presynaptic cholinergic amplifier PG-9.
    Ghelardini C; Galeotti N; Gualtieri F; Marchese V; Bellucci C; Bartolini A
    J Pharmacol Exp Ther; 1998 Mar; 284(3):806-16. PubMed ID: 9495837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of central cholinergic system in antinociception induced by sumatriptan in mouse.
    Ghelardini C; Galeotti N; Nicolodi M; Donaldson S; Sicuteri F; Bartolini A
    Int J Clin Pharmacol Res; 1997; 17(2-3):105-9. PubMed ID: 9403365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of spinal and supra-spinal antinociception of (-)-linalool.
    Peana AT; De Montis MG; Nieddu E; Spano MT; D'Aquila PS; Pippia P
    Eur J Pharmacol; 2004 Feb; 485(1-3):165-74. PubMed ID: 14757137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT1A agonists induce central cholinergic antinociception.
    Galeotti N; Ghelardini C; Bartolini A
    Pharmacol Biochem Behav; 1997 Aug; 57(4):835-41. PubMed ID: 9259013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antinociceptive and sedative effects of carbachol and oxycodone administered into brainstem pontine reticular formation and spinal subarachnoid space in rats.
    Ma HC; Dohi S; Wang YF; Ishizawa Y; Yanagidate F
    Anesth Analg; 2001 May; 92(5):1307-15. PubMed ID: 11323367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation into atropine-induced antinociception.
    Ghelardini C; Malmberg-Aiello P; Giotti A; Malcangio M; Bartolini A
    Br J Pharmacol; 1990 Sep; 101(1):49-54. PubMed ID: 2282466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.